Micotherapy ABM

Description

Agaricus blazei Murrill is especially indicated for the support of organs in contact with the external environment (pleuroperitoneal area), such as the digestive system, liver, bile ducts, pancreas, respiratory tract and lungs.

Experimental clinical studies have highlighted its antioxidant and immunomodulatory hepatoprotective effects against hepatotoxic xenobiotic substances, such as diethylnitrosamine, paracetamol, benzene, benzo(a)pyrene, CCl4, phenylhydrazine, viruses with hepatotoxic action, chemotherapy toxicity, and neuroprotective against the insecticide rotenone., used to induce Parkinson's disease in animal models.

In Micotherapy ABM are present both the hydroalcoholic extract, which contains most of the beta-glucans with immunomodulatory action, a fundamental activity for this fungus, and the whole fungus, which guarantees the presence of secondary metabolites, and which protects the soluble beta-glucans from phenomena excessive degradation in the gastric and duodenal environment.

Properties and benefits of Micotherapy ABM

Very effective as liver support where:

• Improves liver function.
• Reduces liver damage.
• Prevents liver fibrosis by CCl4.
• Increases antioxidant systems (GSH).
• Protects against DNA damage and reduces genotoxicity.

How to take Micotherapy ABM?

1 capsule 3 times a day away from meals.

Composition of Micotherapy ABM

For 3 capsules: Agaricus blazei murrill dry extract 300 mg, Contribution in polysaccharides 75 mg, Agaricus blazei murrill Whole mushroom 1200 mg.

Certificate

IT-BIO-006 Agriculture EU